Literature DB >> 11059123

Current status of hepatitis C in Canada.

S Zou1, M Tepper, A Giulivi.   

Abstract

Mesh：

Year:  2000        PMID： 11059123      PMCID： PMC6979734     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN： 0008-4263


× No keyword cloud information.
  19 in total

1.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study.

Authors:  S A Strathdee; D M Patrick; S L Currie; P G Cornelisse; M L Rekart; J S Montaner; M T Schechter; M V O'Shaughnessy
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

2.  Seroepidemiologic study of hepatitis B and C viruses in federal correctional institutions in British Columbia.

Authors:  R G Préfontaine; R K Chaudhary
Journal:  Can Dis Wkly Rep       Date:  1990-12-29

3.  45-year follow-up of hepatitis C virus infection in healthy young adults.

Authors:  L B Seeff; R N Miller; C S Rabkin; Z Buskell-Bales; K D Straley-Eason; B L Smoak; L D Johnson; S R Lee; E L Kaplan
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

Review 4.  Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features.

Authors:  J L Dienstag
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

Review 5.  Hepatitis C.

Authors:  M J Alter; E E Mast; L A Moyer; H S Margolis
Journal:  Infect Dis Clin North Am       Date:  1998-03       Impact factor: 5.982

Review 6.  Histopathology of hepatitis C virus infection.

Authors:  Z D Goodman; K G Ishak
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

7.  Identification of hepatitis C virus genotypes among hospitalized patients in British Columbia, Canada.

Authors:  M Altamirano; A Delaney; A Wong; J Marostenmaki; D Pi
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

Review 8.  Hepatitis C.

Authors:  A I Sharara; C M Hunt; J D Hamilton
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

9.  Clinical and epidemiologic characteristics of hepatitis C in a gastroenterology/hepatology practice in Ottawa.

Authors:  L J Scully; S Mitchell; P Gill
Journal:  CMAJ       Date:  1993-04-01       Impact factor: 8.262

Review 10.  Hepatitis C: natural history of a unique infection.

Authors:  S Iwarson; G Norkrans; R Wejstål
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079
View more
  19 in total

Review 1.  Treatment of acute HCV infection.

Authors:  Jason Grebely; Gail V Matthews; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

2.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

Review 3.  Update on the clinical use of buprenorphine: in opioid-related disorders.

Authors:  Simon Ducharme; Ronald Fraser; Kathryn Gill
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

4.  Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals.

Authors:  Allison Mah; Mark W Hull; Kora DeBeck; Michael John Milloy; Sabina Dobrer; Ekaterina Nosova; Evan Wood; Thomas Kerr; Kanna Hayashi
Journal:  Int J Drug Policy       Date:  2017-03-24

Review 5.  Hepatitis C: a review for primary care physicians.

Authors:  Tom Wong; Samuel S Lee
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

6.  Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods.

Authors:  Audrey Blasig; Emily C Wagner; David Pi; Mark Bigham; Valencia P Remple; Kevin J P Craib; Patrick Doyle; Simon Dobson; Eric M Yoshida; David Patrick; Mel Krajden; Deborah M Money
Journal:  Can J Public Health       Date:  2011 Mar-Apr

7.  Risk factors for hepatitis C virus infection among street youths.

Authors:  E Roy; N Haley; P Leclerc; J F Boivin; L Cédras; J Vincelette
Journal:  CMAJ       Date:  2001-09-04       Impact factor: 8.262

8.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

9.  An epidemiologic study of hepatocellular carcinoma in Canada.

Authors:  Susie elSaadany; Martin Tepper; Yang Mao; Robert Semenciw; Antonio Giulivi
Journal:  Can J Public Health       Date:  2002 Nov-Dec

10.  Publicly funded pegylated interferon-alpha treatment in British Columbia: disparities in treatment patterns for people with hepatitis C.

Authors:  Priscilla C Hsu; Jane A Buxton; Andrew W Tu; Warren D Hill; Amanda Yu; Mel Krajden
Journal:  Can J Gastroenterol       Date:  2008-04       Impact factor: 3.522
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.